Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
17 Apr 2019, 09:05
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc $OSIR
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc $OSIR
12 Mar 2019, 09:02
Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc $OSIR
Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc $OSIR
26 Nov 2018, 16:30
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer $OSIR
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer $OSIR
7 Nov 2018, 16:15
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results $OSIR
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results $OSIR
show more ▾
featured articles
April 18, 2024
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
April 18, 2024
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
April 17, 2024
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
April 17, 2024
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Osiris Therapeutics, Inc.
OSIR
$OSIR ↻
0 online
Today
This week
Search
Subscribe
No more messages to load
Sign up to become a contributing member of the community.
Trending
Personal channels
